Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) ROE %: 13.69% (As of Dec. 2023)


MIC:GEMA Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA
17 GF Score
Price ₽108.00
View Full Analysis

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC ROE %?

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA -1.73% 17 ROE % is 13.69% as of Dec. 2023. GuruFocus rates MIC:GEMA with a GF Score™ of 17/100.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's annualized net income for the quarter that ended in Dec. 2023 was ₽67.6 Mil. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was ₽493.9 Mil. Therefore, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's annualized ROE % for the quarter that ended in Dec. 2023 was 13.69%.

The historical rank and industry rank for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's ROE % or its related term are showing as below:

MIC:GEMA's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 5.72
* Ranked among companies with meaningful ROE % only.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC  (MIC:GEMA) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=67.64/493.9265
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(67.64 / 280.528)*(280.528 / 1293.0775)*(1293.0775 / 493.9265)
=Net Margin %*Asset Turnover*Equity Multiplier
=24.11 %*0.2169*2.618
=ROA %*Equity Multiplier
=5.23 %*2.618
=13.69 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=67.64/493.9265
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (67.64 / 67.64) * (67.64 / 134.096) * (134.096 / 280.528) * (280.528 / 1293.0775) * (1293.0775 / 493.9265)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.5044 * 47.8 % * 0.2169 * 2.618
=13.69 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC ROE % Related Terms


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC ROE % Historical Data

* Premium members only.

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC ROE % Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial 99.22 60.46 66.34 48.72 28.53

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.15 43.89 23.30 0.00 13.69

MIC:GEMA vs FICO, SPSC, RDVT: ROE % Comparison

For the Medical Care Facilities subindustry, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's ROE % distribution charts can be found below:

* The bar in red indicates where Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's ROE % falls into.


MIC:GEMA
17GF Score
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC ROE % Calculation

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=125.78/( (0+440.877)/ 1 )
=125.78/440.877
=28.53 %

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=67.64/( (546.976+440.877)/ 2 )
=67.64/493.9265
=13.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 13.69% mean?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a ROE % of 13.69% as of Dec. 2023. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's ROE % too high?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current ROE % is 13.69%. The Healthcare Providers & Services industry median ROE % is 5.72. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's value of 13.69% is 139.3% above this industry median. Overall, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's ROE % compare to FICO and SPSC?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's ROE % of 13.69% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROE % is 5.72. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's value of 13.69% is 139.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current ROE % of 13.69% is 139.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current ROE % is 13.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC stock overvalued right now?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a current ROE % of 13.69%. The current ROE % is 13.69% and 139.3% above the Healthcare Providers & Services industry median of 5.72. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA), the current ROE % is 13.69% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Business Description

Address Ulitsa Gubkina, d. 3, Building 1, Floor 1, Moscow, RUS, 119333
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation, and Umbilical Cord tissue, among others.
17GF Score

Get the complete analysis for MIC:GEMA

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₽108.00
Price